Screener
Mirum Pharmaceuticals, Inc. MIRM Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s net income?
- Mirum Pharmaceuticals, Inc. (MIRM) reported net income of -$67.23M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s net income changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s net income decreased by 1047.0% year-over-year, from -$5.86M to -$67.23M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s net income?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s net income has grown at a -44.4% compound annual growth rate (CAGR), from -$135.67M to -$23.36M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Mirum Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude